Fasting during Ramadan is a major challenge for diabetics because of its various risks. A therapeutic management plan can ensure fasting while minimizing the associated risks. Our aim was to implement a pre-Ramadan management program and to define patient profiles that are more adapted to fast. Methods: 262 type 2 diabetic patients were recruited from both 2019 and 2021 Ramadan campaigns organized at the endocrinology department of the Mohammed VI University Hospital of Marrakech, excluding pregnant women and patients with chronic end-stage kidney disease. Results: Predominantly female and aged between 50 and 70 years, with a high BMI. Glycemic control was close to target for fasters. The most common comorbidities in our series were hypertension and dyslipidemia. 19.8% of our patients had an associated cardiovascular complication and 10.5% had kidney disease. After stratification, the non fasting decision concerned most of our diabetics in 2021 compared to 2019. Conclusion: A therapeutic management plan help to fit guidelines. Compared to 2017, the updated 2021 stratification guidelines are more comprehensive and have defined more non fasters patients.